跳至主要内容
临床试验/NCT03024112
NCT03024112已完成不适用

Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients

University of Colorado, Denver2 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2013年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
2
主要终点
Number of Participants With Post-operative Pulmonary Complications

研究概览

简要总结

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.

详细描述

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce ICU and hospital length of stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing Thoracic surgery
  • Planned admission to ICU after surgery

排除标准

  • Younger than 18
  • Breast feeding
  • Known diagnosis of obstructive sleep apnea
  • Current or previous lung transplant
  • Pneumonectomy
  • Home oxygen greater than 4L/minute
  • Inability to adhere to assigned treatment prior to 48 hours of surgery or until transferred to a floor

研究组 & 干预措施

Heated humidified high-flow nasal cannula (HHFNC) oxygen

Experimental

The intervention group received HHFNC O2 at a set flow of 40L/min. FiO2 was titrated by respiratory therapists to maintain SpO2 ≥ 90%. The HHFNC O2 apparatus included: 1) Air-Oxygen blender - capable of delivering 21-100% FiO2 at flow rates up to 60L/min, 2) Heated Humidifier - providing active heating and humidification to the delivered air-O2 blend, 3) Nasal cannula - larger diameter, slightly elongated nasal cannula with single limb connection to humidifier

干预措施: Heated humified high-flow nasal cannula Oxygen (Device)

Standard oxygen Therapy

Active Comparator

The standard O2 treatment group received usual nasal cannula or face mask oxygen titrated by nurses as necessary to maintain SpO2 ≥ 90%.

干预措施: Standard oxygen therapy (Other)

结局指标

主要结局

Number of Participants With Post-operative Pulmonary Complications

时间窗: 30 days

The primary outcome "post-operative pulmonary complication" is defined as present if any one of the following criteria are met: * SpO2 \< 90% with FiO2 ≥ 50% * Dyspnea at rest * Respiratory rate \> 25 breaths/min * Active use of accessory respiratory muscles * PaO2/FiO2 ratio \< 200 * Escalation of therapy to non-invasive ventilation * Re-intubation * Occurrence of hospital-acquired pneumonia * Re-admission to the ICU

次要结局

  • ICU Length of Stay(30 days)
  • Hospital Length of Stay(30 days)
  • Lowest Oxygen Saturation Level Measured(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Impact of Prophylactic High Flow Nasal Oxygen in... | 临床试验